Patents by Inventor Yu-Ri Moon

Yu-Ri Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8546093
    Abstract: The present invention relates to an antibody against a protein specifically expressed in methicillin-resistant strains of Staphylococcus aureus (MRSA), and a method and a kit for detecting MRSA. The present invention enables a fast and accurate detection of MRSA by using both a PBP2a-specific antibody for the detection of PBP2a and a Protein A-specific antibody for the detection of Protein A.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: October 1, 2013
    Assignee: Dinona Inc.
    Inventors: Hyung-Geun Song, Sang-Soon Yoon, Hae-Jung Kim, Gil-Yong Jee, Mi-Hyang Shin, Yu-Ri Moon
  • Patent number: 8404812
    Abstract: The present invention relates to epitope of CD66c specific to lung adenocarcinoma and antibody recognizing the same. The present invention relates to identifying epitope of CD66c specific to lung adenocarcinoma, antibody recognizing the same, cell lines producing the same and the applications in diagnosis, prevention and treatment of lung adenocarcinoma by using the same. The above CD66c epitope is specific to lung adenocarcinoma cells, and therefore the antibody or its fragment recognizing the epitope can be used in compositions to diagnose, treat and prevent lung adenocarcinoma cells.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: March 26, 2013
    Assignee: Dinona Inc.
    Inventors: Hyung-Geun Song, Sang-Sun Yoon, Mi-Hyang Shin, Yu-Ri Moon
  • Publication number: 20120070851
    Abstract: The present invention relates to an antibody against a protein specifically expressed in methicillin-resistant strains of Staphylococcus aureus (MRSA), and a method and a kit for detecting MRSA. The present invention enables a fast and accurate detection of MRSA by using both a PBP2a-specific antibody for the detection of PBP2a and a Protein A-specific antibody for the detection of Protein A.
    Type: Application
    Filed: June 24, 2009
    Publication date: March 22, 2012
    Applicant: DiNonA Inc.
    Inventors: Hyung-Geun Song, Sang-Soon Yoon, Hae-Jung Kim, Gil-Yong Jee, Mi-Hyang Shin, Yu-Ri Moon
  • Publication number: 20110212095
    Abstract: The present invention relates to epitope of CD66c specific to lung adenocarcinoma and antibody recognizing the same. The present invention relates to identifying epitope of CD66c specific to lung adenocarcinoma, antibody recognizing the same, cell lines producing the same and the applications in diagnosis, prevention and treatment of lung adenocarcinoma by using the same. The above CD66c epitope is specific to lung adenocarcinoma cells, and therefore the antibody or its fragment recognizing the epitope can be used in compositions to diagnose, treat and prevent lung adenocarcinoma cells.
    Type: Application
    Filed: August 26, 2010
    Publication date: September 1, 2011
    Applicant: DiNonA Inc.
    Inventors: Hyung-Geun SONG, Sang-Sun Yoon, Mi-Hyang Shin, Yu-Ri Moon